With the goal of reducing the copayment amounts required of patients, the Korean government first established the Mid-Term National Health Insurance Plan for the period from 2005 to 2008, and followed it up with two subsequent Reinforced Mid-Term Insurance Plans spanning 2009 to 2013 and 2014 to 2018, consistently expanding the range of health insurance coverage for the Korean public. As a result, the copayment rate for cancer patients was reduced from 20% to 10% in September 2005, and again to 5% in December 2009. Although the Korean government has been increasing health insurance coverage and benefits for serious diseases, including cancer, some criticize this policy trend on the grounds that it encourages moral hazard and a supplier-induced rise in demand for health services. The decreasing cost burden on patients leads to greater competition among medical institutions to attract patients and may increase demand for large hospitals equipped with high-tech equipment and high-caliber medical professionals, thereby aggravating the concentration of patients. This study analyzes the effect of increasing health insurance coverage on the use of medical services in relation to supplier characteristics, with a view to estimating the impact of the policy and highlighting future policy implications.
Table Of Contents
Abstract 1 요 약 3 제1장 서 론 7 제1절 연구의 필요성 및 배경 9 제2절 연구 내용 및 방법 11 제3절 선행연구 고찰 18 제2장 건강보험 보장성 강화정책 29 제1절 건강보험 보장성 강화 정책 방향 31 제2절 암질환 보장성 강화정책 세부 현황 43 제3장 암 발생 현황 관련 통계 및 진료비 실태조사 통계 77 제1절 중앙암등록본부 자료 79 제2절 국민건강보험공단 진료비 실태조사(2014년) 89 제4장 암 종별 주요 진단검사와 치료방법 103 제1절 대장암 105 제2절 유방암 112 제3절 전립선암 121 제5장 암 종별 분석결과 151 제1절 대장암 153 제2절 유방암 186 제3절 전립선암 207 제4절 소결 227 참고문헌 237 부 록 암질환별 항암제, 방사선치료, 영상검사, 수술코드 239